AstraZeneca, Daiichi Sankyo and Summit Build a Cost-Sharing Cancer Trial Pact Around Datroway and Ivonescimab
Three companies, three assets, shared costs: how the AstraZeneca, Daiichi Sankyo and Summit trial pact works and what it signals for oncology deals.